查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813837

智慧吸入器市場規模、佔有率和趨勢分析報告：按類型、適應症、分銷管道、最終用途、地區和細分市場預測，2025 年至 2033 年

Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, Pulmonary Disease), By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

智慧吸入器市場摘要

預計 2024 年全球智慧吸入器市場價值將達到 184 億美元，到 2033 年將達到 919 億美元，2025 年至 2033 年的複合年成長率為 19.6%。

全球慢性呼吸系統疾病 (CRD) 盛行率的上升、技術先進產品的市場發展以及醫療保健領域數位解決方案的日益普及預計將促進市場的成長。

美國肺臟協會估計，到 2022 年，將有 1,170 萬人（佔成年人的 4.6%）被診斷出患有 COPD，這是一種包括慢性支氣管炎和肺氣腫的疾病。此外，世界衛生組織估計，到 2030 年，包括 COPD、肺癌和結核病在內的潛在致命呼吸道疾病將佔全球死亡人數的約五分之一。

人們對智慧吸入器發展的日益關注以及主要市場參與者加強的研發力度，推動了智慧吸入器的需求。此外，越來越多的公司將數位技術融入其產品中，以提高藥物療效以及氣喘和慢性阻塞性肺病（COPD）的管理。例如，2022年4月，市場參與者阿普塔製藥（Aptar Pharma）推出了HeroTracker Sense，這是一款慢性呼吸道數位電子健康解決方案，可將傳統的定量吸入器轉換為智慧吸入器。

此外，各種研究強調了採用智慧吸入器的好處，例如幫助患者堅持治療和控制症狀，這也促進了市場的成長。例如，克利夫蘭診所2020年的一項研究發現，使用Propeller智慧吸入器的慢性阻塞性肺病患者住院風險顯著降低，門診就診次數與前一年相比減少了近35%。

此外，數位醫療技術和連網型設備的日益普及，正在提高患者依從性，實現遠端監控和個人化治療方案。藍牙和感測器技術的整合，使醫療保健提供者能夠追蹤吸入器的使用情況並最佳化治療效果。政府的支持性政策、日益增強的疾病管理意識以及製藥公司和科技公司之間的合作，進一步推動了市場擴張。此外，向價值導向型醫療保健的轉變也推動了智慧吸入器的普及。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章智慧吸入器市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 產業分析
    • 使用者觀點分析
    • 主要最終用戶
  • 技術展望
  • 法律規範
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業挑戰與機會分析
  • 智慧型吸入器市場分析工具
    • 波特分析
    • PESTEL分析

第4章智慧吸入器市場：類型估計和趨勢分析

  • 定義和範圍
  • 2024 年及 2033 年類型市佔率分析
  • 細分儀表板
  • 2021-2033年智慧型吸入器市場（按類型）
    • 乾粉吸入器（DPI）
    • 定量噴霧吸入器（MDI）

第5章智慧吸入器市場：適應症與趨勢分析

  • 定義和範圍
  • 2024年及2033年指示市佔率分析
  • 細分儀表板
  • 智慧吸入器市場（按適應症），2021-2033
    • 氣喘
    • COPD
    • 其他

第6章：智慧吸入器市場：通路評估與趨勢分析

  • 定義和範圍
  • 2024年及2033年通路市佔率分析
  • 細分儀表板
  • 2021-2033 年智慧吸入器市場（按分銷管道）
    • 醫院藥房
    • 零售藥局
    • 網路藥局

第7章智慧吸入器市場：最終用途估計與趨勢分析

  • 定義和範圍
  • 2024年及2033年最終用途市佔率分析
  • 細分儀表板
  • 2021-2033 年智慧吸入器市場（依最終用途）
    • 醫院
    • 居家護理
    • 其他

第8章智慧吸入器市場：按國家、類型、適應症、分銷管道和最終用途區域進行的估計和趨勢分析

  • 定義和範圍
  • 2024 年及 2033 年區域市佔率分析
  • 區域市場儀表板
  • 區域市場概況
  • SWOT分析
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 2024年公司市佔率分析（%）
  • 公司熱圖分析
  • 戰略地圖
    • 擴張
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 研究與開發
  • 公司簡介
    • Presspart Verwaltungs GmbH.
    • Personal Air Quality Systems Pvt Ltd
    • COHERO Health Inc.（AptarGroup, Inc.）
    • Cognita Labs
    • Adherium
    • Amiko Digital Health Limited.
    • Teva Pharmaceuticals Industries Ltd.
    • Propeller Health（ResMed）
    • Novartis AG
    • Pneuma Respiratory Inc.
    • 3M
    • AireHealth, Inc.
    • FindAir Sp. z oo
Product Code: GVR-4-68039-993-1

Smart Inhalers Market Summary

The global smart inhalers market size was estimated at USD 18.4 billion in 2024 and is projected to reach USD 91.9 billion by 2033, growing at a CAGR of 19.6% from 2025 to 2033. The rising prevalence of chronic respiratory diseases (CRDs) globally, the development of technologically advanced products, and the growing adoption of digital solutions in the healthcare sector are expected to contribute to the market's growth.

According to estimates from the American Lung Association, in 2022, 11.7 million people, or 4.6% of adults, reported a diagnosis of COPD, including chronic bronchitis and emphysema. In addition, the WHO estimates that potentially fatal respiratory diseases, including COPD, lung cancer, and tuberculosis, will account for about one in five deaths worldwide by 2030.

The increasing focus on developing smart inhalers and a rise in initiatives by key market players for R&D efforts drive the demand for smart inhalers. In addition, more companies are integrating digital technologies into their product offerings to enhance medication effectiveness and the management of asthma and COPD. For instance, in April 2022, Aptar Pharma, a market player, introduced HeroTracker Sense, a chronic respiratory digital e-health solution that converts a conventional metered dose inhaler into a smart inhaler.

Moreover, various research studies highlighting the benefits of adopting smart inhalers, such as assisting patients in treatment adherence and controlling symptoms, also contribute to the market growth. For instance, a 2020 Cleveland Clinic study discovered that patients with COPD using the Propeller company's smart inhalers had a noticeably lower risk of being admitted to the hospital, with a nearly 35% drop in visits compared to the prior year.

Furthermore, increasing adoption of digital health technologies and connected devices is enabling better patient adherence, remote monitoring, and personalized treatment plans. Integration of Bluetooth and sensor-based technologies allows healthcare providers to track inhaler usage and optimize therapy outcomes. Supportive government initiatives, growing awareness about disease management, and collaborations between pharmaceutical companies and tech firms are further accelerating market expansion. In addition, the shift toward value-based care is encouraging the adoption of smart inhalers.

Global Smart Inhalers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global smart inhalers market report based on type, indication, distribution channel, end use, and region.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Dry Powdered Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Asthma
  • COPD
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Homecare Settings
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Indication Outlook
    • 2.2.3. Distribution Channel Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Smart Inhalers Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Industry Analysis
    • 3.2.1. User Perspective Analysis
    • 3.2.2. Key End Users
  • 3.3. Technology Outlook
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Drivers Analysis
      • 3.5.1.1. Rising prevalence of respiratory diseases
      • 3.5.1.2. Development of technologically advanced solutions
      • 3.5.1.3. Growing adoption of digital health technologies
    • 3.5.2. Market Restraints Analysis
      • 3.5.2.1. Higher cost than traditional inhalers
    • 3.5.3. Industry Challenges and Opportunity Analysis
  • 3.6. Smart Inhalers Market Analysis Tools
    • 3.6.1. Porter's Analysis
      • 3.6.1.1. Bargaining power of the suppliers
      • 3.6.1.2. Bargaining power of the buyers
      • 3.6.1.3. Threats of substitution
      • 3.6.1.4. Threats from new entrants
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic and Social landscape
      • 3.6.2.3. Technological landscape
      • 3.6.2.4. Environmental landscape
      • 3.6.2.5. Legal landscape

Chapter 4. Smart Inhalers Market: Type Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Smart Inhalers Market: By Type, 2021 to 2033
    • 4.4.1. Dry Powdered Inhalers (DPIs)
      • 4.4.1.1. Dry Powdered Inhalers (DPIs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.2. Metered Dose Inhalers (MDIs)
      • 4.4.2.1. Metered Dose Inhalers (MDIs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Smart Inhalers Market: Indication Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Indication Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Smart Inhalers Market: By Indication, 2021 to 2033
    • 5.4.1. Asthma
      • 5.4.1.1. Asthma Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 5.4.2. COPD
      • 5.4.2.1. COPD Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 5.4.3. Others
      • 5.4.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Smart Inhalers Market: Distribution Channel Estimates& Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Distribution Channel Market Share Analysis, 2024 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Smart Inhalers Market: By Distribution Channel, 2021 to 2033
    • 6.4.1. Hospital Pharmacies
      • 6.4.1.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 6.4.2. Retail Pharmacies
      • 6.4.2.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 6.4.3. Online Pharmacies
      • 6.4.3.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Smart Inhalers Market: End Use Estimates& Trend Analysis

  • 7.1. Definition and Scope
  • 7.2. End Use Market Share Analysis, 2024 & 2033
  • 7.3. Segment Dashboard
  • 7.4. Smart Inhalers Market: By End Use, 2021 to 2033
    • 7.4.1. Hospital
      • 7.4.1.1. Hospital Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.2. Homecare Settings
      • 7.4.2.1. Homecare Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.3. Others
      • 7.4.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Smart Inhalers Market: Regional Estimates & Trend Analysis by Country, Type, Indication, Distribution Channel, End Use

  • 8.1. Definition and Scope
  • 8.2. Regional Market Share Analysis, 2024 & 2033
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. SWOT Analysis
    • 8.5.1. North America
    • 8.5.2. Europe
    • 8.5.3. Asia Pacific
    • 8.5.4. Latin America
    • 8.5.5. Middle East & Africa
  • 8.6. Smart Inhalers Market Share, By Region, 2024 & 2033 (USD Billion)
  • 8.7. North America
    • 8.7.1. North America Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.2. U.S.
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. U.S. Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.3. Canada
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Canada Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.4. Mexico
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.4.3. Competitive Insights
      • 8.7.4.4. Mexico Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.8. Europe
    • 8.8.1. Europe Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.2. UK
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. UK Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.3. Germany
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Germany Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.4. France
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. France Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.5. Italy
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Italy Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.6. Spain
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.6.3. Competitive Insights
      • 8.8.6.4. Spain Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.7. Sweden
      • 8.8.7.1. Key Country Dynamics
      • 8.8.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.7.3. Competitive Insights
      • 8.8.7.4. Sweden Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.8. Denmark
      • 8.8.8.1. Key Country Dynamics
      • 8.8.8.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.8.3. Competitive Insights
      • 8.8.8.4. Denmark Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.9. Norway
      • 8.8.9.1. Key Country Dynamics
      • 8.8.9.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.9.3. Competitive Insights
      • 8.8.9.4. Norway Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.9. Asia Pacific
    • 8.9.1. Asia Pacific Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.2. China
      • 8.9.2.1. Key Country Dynamics
      • 8.9.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.2.3. Competitive Insights
      • 8.9.2.4. China Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.3. Japan
      • 8.9.3.1. Key Country Dynamics
      • 8.9.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.3.3. Competitive Insights
      • 8.9.3.4. Japan Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.4. India
      • 8.9.4.1. Key Country Dynamics
      • 8.9.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.4.3. Competitive Insights
      • 8.9.4.4. India Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.5. South Korea
      • 8.9.5.1. Key Country Dynamics
      • 8.9.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.5.3. Competitive Insights
      • 8.9.5.4. South Korea Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.6. Australia
      • 8.9.6.1. Key Country Dynamics
      • 8.9.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.6.3. Competitive Insights
      • 8.9.6.4. Australia Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.7. Thailand
      • 8.9.7.1. Key Country Dynamics
      • 8.9.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.7.3. Competitive Insights
      • 8.9.7.4. Thailand Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.10. Latin America
    • 8.10.1. Latin America Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.10.2. Brazil
      • 8.10.2.1. Key Country Dynamics
      • 8.10.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.2.3. Competitive Insights
      • 8.10.2.4. Brazil Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.10.3. Argentina
      • 8.10.3.1. Key Country Dynamics
      • 8.10.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.3.3. Competitive Insights
      • 8.10.3.4. Argentina Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.11. Middle East and Africa
    • 8.11.1. Middle East and Africa Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.11.2. South Africa
      • 8.11.2.1. Key Country Dynamics
      • 8.11.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.2.3. Competitive Insights
      • 8.11.2.4. South Africa Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.11.3. Saudi Arabia
      • 8.11.3.1. Key Country Dynamics
      • 8.11.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.3.3. Competitive Insights
      • 8.11.3.4. Saudi Arabia Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.11.4. UAE
      • 8.11.4.1. Key Country Dynamics
      • 8.11.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.4.3. Competitive Insights
      • 8.11.4.4. UAE Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.11.5. Kuwait
      • 8.11.5.1. Key Country Dynamics
      • 8.11.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.5.3. Competitive Insights
      • 8.11.5.4. UAE Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis, 2024 (%)
  • 9.4. Company Heat Map Analysis
  • 9.5. Strategy Mapping
    • 9.5.1. Expansion
    • 9.5.2. Mergers & Acquisition
    • 9.5.3. Partnerships & Collaborations
    • 9.5.4. New Product Launches
    • 9.5.5. Research And Development
  • 9.6. Company Profiles
    • 9.6.1. Presspart Verwaltungs GmbH.
      • 9.6.1.1. Participant's Overview
      • 9.6.1.2. Financial Performance
      • 9.6.1.3. Product Benchmarking
      • 9.6.1.4. Recent Developments
    • 9.6.2. Personal Air Quality Systems Pvt Ltd
      • 9.6.2.1. Participant's Overview
      • 9.6.2.2. Financial Performance
      • 9.6.2.3. Product Benchmarking
      • 9.6.2.4. Recent Developments
    • 9.6.3. COHERO Health Inc. (AptarGroup, Inc.)
      • 9.6.3.1. Participant's Overview
      • 9.6.3.2. Financial Performance
      • 9.6.3.3. Product Benchmarking
      • 9.6.3.4. Recent Developments
    • 9.6.4. Cognita Labs
      • 9.6.4.1. Participant's Overview
      • 9.6.4.2. Financial Performance
      • 9.6.4.3. Product Benchmarking
      • 9.6.4.4. Recent Developments
    • 9.6.5. Adherium
      • 9.6.5.1. Participant's Overview
      • 9.6.5.2. Financial Performance
      • 9.6.5.3. Product Benchmarking
      • 9.6.5.4. Recent Developments
    • 9.6.6. Amiko Digital Health Limited.
      • 9.6.6.1. Participant's Overview
      • 9.6.6.2. Financial Performance
      • 9.6.6.3. Product Benchmarking
      • 9.6.6.4. Recent Developments
    • 9.6.7. Teva Pharmaceuticals Industries Ltd.
      • 9.6.7.1. Participant's Overview
      • 9.6.7.2. Financial Performance
      • 9.6.7.3. Product Benchmarking
      • 9.6.7.4. Recent Developments
    • 9.6.8. Propeller Health (ResMed)
      • 9.6.8.1. Participant's Overview
      • 9.6.8.2. Financial Performance
      • 9.6.8.3. Product Benchmarking
      • 9.6.8.4. Recent Developments
    • 9.6.9. Novartis AG
      • 9.6.9.1. Participant's Overview
      • 9.6.9.2. Financial Performance
      • 9.6.9.3. Product Benchmarking
      • 9.6.9.4. Recent Developments
    • 9.6.10. Pneuma Respiratory Inc.
      • 9.6.10.1. Participant's Overview
      • 9.6.10.2. Financial Performance
      • 9.6.10.3. Product Benchmarking
      • 9.6.10.4. Recent Developments
    • 9.6.11. 3M
      • 9.6.11.1. Participant's Overview
      • 9.6.11.2. Financial Performance
      • 9.6.11.3. Product Benchmarking
      • 9.6.11.4. Recent Developments
    • 9.6.12. AireHealth, Inc.
      • 9.6.12.1. Participant's Overview
      • 9.6.12.2. Financial Performance
      • 9.6.12.3. Product Benchmarking
      • 9.6.12.4. Recent Developments
    • 9.6.13. FindAir Sp. z o.o
      • 9.6.13.1. Participant's Overview
      • 9.6.13.2. Financial Performance
      • 9.6.13.3. Product Benchmarking
      • 9.6.13.4. Recent Developments

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 4 North America smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 5 North America smart inhalers market estimates and forecasts by distribution channel, 2021 - 2033 (USD Million)
  • Table 6 North America smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 7 U.S. smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 8 U.S. smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 9 U.S. smart inhalers market estimates and forecasts by distribution channel, 2021 - 2033 (USD Million)
  • Table 10 U.S. smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 11 Canada smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 12 Canada smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 13 Canada smart inhalers market estimates and forecasts by distribution channel, 2021 - 2033 (USD Million)
  • Table 14 Canada smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 15 Mexico smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 16 Mexico smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 17 Mexico smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 18 Mexico smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 20 Europe smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 21 Europe smart inhalers market estimates and forecasts by distribution channel, 2021 - 2033 (USD Million)
  • Table 22 Europe smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 23 UK smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 24 UK smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 25 UK smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 26 UK smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 27 Germany smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 28 Germany smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 29 Germany smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 30 Germany smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 31 France smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 32 France smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 33 France smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 34 France smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 35 Italy smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 36 Italy smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 37 Italy smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 38 Italy smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 39 Spain smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 40 Spain smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 41 Spain smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 42 Spain smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 43 Sweden smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 44 Sweden smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 45 Sweden smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 46 Sweden smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 47 Denmark smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 48 Denmark smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 49 Denmark smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 50 Denmark smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 51 Norway smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 52 Norway smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 53 Norway smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 54 Norway smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 55 Asia Pacific smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 56 Asia Pacific smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 59 Japan smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 60 Japan smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 61 Japan smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 62 Japan smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 63 China smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 64 China smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 65 China smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 66 China smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 67 India smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 68 India smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 69 India smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 70 India smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 71 Australia smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 72 Australia smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 73 Australia smart inhalers market estimates and forecasts by distribution channel, 2021 - 2033 (USD Million)
  • Table 74 Australia smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 75 South Korea smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 76 South Korea smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 77 South Korea smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 78 Thailand smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 79 Thailand smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 80 Thailand smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 81 Thailand smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 82 Latin America smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 83 Latin America smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 84 Latin America smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 85 Latin America smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 86 Brazil smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 87 Brazil smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 88 Brazil smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 89 Brazil smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 90 Argentina smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 91 Argentina smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 92 Argentina smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 93 Argentina smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 94 MEA smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 95 MEA smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 96 MEA smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 97 MEA smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 98 South Africa smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 99 South Africa smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 100 South Africa smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 101 South Africa smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 102 Saudi Arabia smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 103 Saudi Arabia smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 104 Saudi Arabia smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 105 Saudi Arabia smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 106 UAE smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 107 UAE smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 108 UAE smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 109 UAE smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 110 Kuwait smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 111 Kuwait smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 112 Kuwait smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 113 Kuwait smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 Smart Inhalers Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (1/2)
  • Fig. 9 Segment Snapshot (2/2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 Smart Inhalers- Market Size and Growth Prospects (USD Million)
  • Fig. 12 Smart Inhalers Market : Industry Value Chain Analysis
  • Fig. 13 Smart Inhalers Market : Market Dynamics
  • Fig. 14 Smart Inhalers Market : PORTER's Analysis
  • Fig. 15 Smart Inhalers Market : PESTEL Analysis
  • Fig. 16 Smart Inhalers Market Share by type 2024 & 2030 (USD Million)
  • Fig. 17 Smart Inhalers Market,by type: Market Share, 2024 & 2030
  • Fig. 18 Dry Powdered Inhalers (DPIs) Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Metered Dose Ihalers (MDIs) Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 Smart Inhalers Market, by Indication: Key Takeaways
  • Fig. 21 Smart Inhalers Market, by Indication: Market Share, 2024 & 2030
  • Fig. 22 Asthma Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 COPD Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 24 Others Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 25 Smart Inhalers Market, by Distribution Channel: Key Takeaways
  • Fig. 26 Smart Inhalers Market, by Distribution Channel: Market Share, 2024 & 2030
  • Fig. 27 Hospital Pharmacies Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 28 Retail Pharmacies Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 29 Online Pharmacies Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 30 Smart Inhalers Market, by End Use: Key Takeaways
  • Fig. 31 Smart Inhalers Market, by End Use: Market Share, 2024 & 2030
  • Fig. 32 Hospitals Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 33 Homecare Settings Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 34 Others Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 35 Smart Inhalers Market Revenue, by Region, 2024 & 2030, (USD Million)
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 Regional Marketplace: Key Takeaways
  • Fig. 38 North America Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Canada Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Mexico Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Europe Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 UK Smart Inhalers Market Estimates and Forecasts, 2021 - 2033) (USD Million)
  • Fig. 44 Germany Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 France Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Italy Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Spain Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Sweden Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Denmark Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Norway Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Asia Pacific Smart Inhalers Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Japan Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 China Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 India Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Australia Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Thailand Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Latin America Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Brazil Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Argentina Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 MEA Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Saudi Arabia Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 UAE Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 South Africa Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Kuwait Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key Company Categorization
  • Fig. 66 Company Market Positioning
  • Fig. 67 Key Company Market Share Analysis, 2024
  • Fig. 68 Strategic Framework